Paradigm Biopharmaceuticals Ltd. (PBIGF)
OTHER OTC:PBIGF
Holding PBIGF?
Track your performance easily

Paradigm Biopharmaceuticals Ltd. (PBIGF) Cash flow

12 Followers

Paradigm Biopharmaceuticals Ltd. Cash Flow

PBIGF's free cash flow for Q4 2022 was AU$―. For the 2022 fiscal year, PBIGF's free cash flow was decreased by AU$2.76M and operating cash flow was AU$―. See a summary of the company’s cash flow.
Cash Flow
TTM
Jun 22Jun 21Jun 20Jun 19Jun 18
Operating Cash Flow
------
Investing Cash Flow
--AU$ 668.37KAU$ 5.62MAU$ -6.52MAU$ -15.34K
Financing Cash Flow
-AU$ 70.12KAU$ 1.00MAU$ 36.05MAU$ 82.78MAU$ 5.88M
Cash Flow From Discontinued Operation
------
Other Cash Adjustment Inside Changein Cash
------
End Cash Position
-AU$ 39.67MAU$ 71.03MAU$ 103.92MAU$ 72.34MAU$ 2.45M
Income Tax Paid Supplemental Data
------
Interest Paid Supplemental Data
-AU$ 28.63KAU$ 37.72KAU$ 34.17K--
Issuance Of Capital Stock
--AU$ 1.02MAU$ 36.84MAU$ 88.05MAU$ 6.51M
Issuance Of Debt
-AU$ 205.29KAU$ 103.67KAU$ 1.90M--
Repayment Of Debt
------
Free Cash Flow
-AU$ -32.21MAU$ -34.96MAU$ -10.22MAU$ -6.39MAU$ -6.03M
Domestic Sales
------
Foreign Sales
------
Currency in AUD

Paradigm Biopharmaceuticals Ltd. Cash Flow

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis